Childhood Apraxia of Speech Clinical Trial
Official title:
Treating Childhood Apraxia of Speech: Role of Biofeedback & Practice Distribution
Verified date | May 2023 |
Source | Syracuse University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study will test two modifications to speech therapy for 40 school-age children with childhood apraxia of speech to determine how to improve treatment outcomes. The study will compare treatment that includes real-time visual feedback of the tongue during speech using ultrasound vs traditional therapy that does not include ultrasound visual feedback. Additionally, some children will be treated with a traditional schedule of 2 sessions per week, whereas others will be provided with treatment that begins with intensive training (10 hours of therapy in one week) and progresses to a more distributed treatment schedule.
Status | Completed |
Enrollment | 56 |
Est. completion date | June 7, 2022 |
Est. primary completion date | May 9, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Years to 17 Years |
Eligibility | Inclusion Criteria: - Native English speakers who hear English as the dominant language in their home setting. - Must pass a hearing screening. - Score at or better than -2 standard deviations from the mean on the Matrix Reasoning Task of the Wechsler Abbreviated Scale of Intelligence - 2nd Edition (WASI-2; t-score = 30), Peabody Picture Vocabulary Test - 4th Edition (PPVT-4; standard score = 70), and the Following Directions subtest of the Clinical Evaluation of Language Fundamentals - 5th Edition (CELF-5; scaled score = 3). - Goldman-Fristoe Test of Articulation - 3rd Edition (GFTA-3) percentile = 5th). - A diagnosis of CAS will be verified based on a polysyllable picture naming task, diadochokinetic task (puh-tuh-kuh), and syllable repetition task. Exclusion Criteria: - Parent report or direct evaluation reveals oral-facial structural abnormalities (e.g., cleft palate). - Parental report of neurobehavioral disorders (e.g., autism spectrum disorders, ADHD, obsessive-compulsive disorder), or vision problems that are corrected with glasses/contacts. - Fail a hearing screening, or failure to meet criteria listed above as Inclusionary |
Country | Name | City | State |
---|---|---|---|
United States | Syracuse University | Syracuse | New York |
Lead Sponsor | Collaborator |
---|---|
Syracuse University | National Institute on Deafness and Other Communication Disorders (NIDCD) |
United States,
Preston JL, Leece MC, Maas E. Intensive Treatment with Ultrasound Visual Feedback for Speech Sound Errors in Childhood Apraxia. Front Hum Neurosci. 2016 Aug 30;10:440. doi: 10.3389/fnhum.2016.00440. eCollection 2016. — View Citation
Preston JL, Leece MC, McNamara K, Maas E. Variable Practice to Enhance Speech Learning in Ultrasound Biofeedback Treatment for Childhood Apraxia of Speech: A Single Case Experimental Study. Am J Speech Lang Pathol. 2017 Aug 15;26(3):840-852. doi: 10.1044/2017_AJSLP-16-0155. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Speech Sound Accuracy | Percent consonants correct for target sounds: The primary outcome measure was percent correct for each participant's target sound-positions in untreated phrase. Participants imitated 20 pre-recorded phrases, each containing the target sound pattern 2 times per stimulus (e.g., for /l/ onset, "leave the location"), resulting in 40 attempts at each sound-position. For each session, 3 transcribers independently transcribed in Phon software (Hedlund & Rose, 2022) and accuracy was averaged across transcribers. Instances where IPA symbols for the Actual transcription differed from the Target transcription was scored as incorrect. | 10 weeks from the start of treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04832503 -
Childhood Apraxia of Speech: Experience Dependent Changes Induced by Treatment
|
||
Recruiting |
NCT04642053 -
A Randomized Control Trial of Motor-based Intervention for CAS
|
N/A | |
Recruiting |
NCT05185583 -
Methylphenidate in Childhood Apraxia of Speech
|
Phase 2 | |
Recruiting |
NCT05675306 -
Dose Frequency RCT on DTTC in Children With CAS
|
N/A | |
Recruiting |
NCT05916222 -
The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS
|
N/A | |
Recruiting |
NCT03903120 -
ASSIST: Treatment for Childhood Apraxia of Speech
|
Phase 1 | |
Recruiting |
NCT06385470 -
Treatment of Cantonese Speakers With Childhood Apraxia of Speech
|
N/A |